Marco Massari to Receptors, Interleukin-6
This is a "connection" page, showing publications Marco Massari has written about Receptors, Interleukin-6.
Connection Strength
0.149
-
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165.
Score: 0.119
-
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):24-31.
Score: 0.030